Treatment patterns of targeted and nontargeted therapies and survival effects in patients with locally advanced head and neck cancer in Taiwan

BACKGROUND: Taiwan’s National Health Insurance has covered targeted therapy, namely cetuximab, for locally advanced head and neck cancers (LAHNC) since July 2009. This study examines treatment trends and survival effects of locally advanced head and neck cancer patients before and after Taiwan’s Nat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Szu-Han, Huang, Ming-Yii, Chen, Chung-Yu, Hsieh, Hui-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283176/
https://www.ncbi.nlm.nih.gov/pubmed/37340424
http://dx.doi.org/10.1186/s12885-023-11061-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10283176/
https://www.ncbi.nlm.nih.gov/pubmed/37340424
http://dx.doi.org/10.1186/s12885-023-11061-4

Ejemplares similares